Business & Industry
Business & Industry
AstraZeneca Secures Global Rights for Zegfrovy Lung Cancer Therapy
AstraZeneca has expanded its oncology pipeline through a $1.5 billion agreement with Dizal Pharma, securing the Zegfrovy global rights. This oral lung cancer therapy, also known as sunvozertinib, is an irreversible EGFR inhibitor. Currently, sunvozertinib is approved in China...
Business & Industry
FDA Proposes New Rule for Drug Manufacturing Registration
The modernization of regulatory frameworks is becoming essential to support the pharmaceutical industry’s transition toward advanced production models and to ensure the resilience of global supply chains. As innovative manufacturing technologies emerge, traditional oversight mechanisms must evolve to maintain...
Business & Industry
In Vivo CAR-T Engineering Sets a New Oncology Standard
The emergence of chimeric antigen receptor T cell therapy has been one of the most significant breakthroughs in the history of hematology oncology. By re engineering a patient’s own immune cells to recognize and attack cancer, researchers have achieved...
Business & Industry
Radioligand Therapy Advances in Precision Oncology
The oncology sector is witnessing a fundamental change in the way systemic radiation is delivered to patients. Historically, radiotherapy was administered from an external source, which, while effective at killing tumor cells, often caused significant damage to the surrounding...
Business & Industry
Proximity Therapeutics Unlock New Druggable Frontiers
The pharmaceutical industry has historically focused on a narrow subset of the human proteome. For decades, the majority of small molecule drugs were designed to bind to the active sites of enzymes or receptors, effectively inhibiting their function. While...
BioPharma
CDMO Strategies Powering the Next-Gen Biopharma Surge
The biopharmaceutical sector is currently navigating an era of unprecedented growth and technological complexity. As the global drug pipeline shifts toward advanced modalities such as cell and gene therapies, bispecific antibodies, and complex mRNA formulations, the demands placed on...
Business & Industry
Why Pharma Supply Chain Resilience Demands Immediate Action
The global pharmaceutical industry is currently facing a critical period of self reflection regarding the stability and reliability of its logistics networks. For years, the sector prioritized cost optimization and just in time manufacturing, leading to a highly centralized...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read